- Home
- ETNB vs BELFA Comparison
ETNB vs BELFA Comparison
Compare ETNB & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETNB
- BELFA
- Stock Information
- Founded
- ETNB 2018
- BELFA 1949
- Country
- ETNB United States
- BELFA United States
- Employees
- ETNB N/A
- BELFA N/A
- Industry
- ETNB Biotechnology: Pharmaceutical Preparations
- BELFA
- Sector
- ETNB Health Care
- BELFA
- Exchange
- ETNB Nasdaq
- BELFA Nasdaq
- Market Cap
- ETNB 1.5B
- BELFA 1.5B
- IPO Year
- ETNB 2019
- BELFA N/A
- Fundamental
- Price
- ETNB $9.23
- BELFA $112.32
- Analyst Decision
- ETNB Strong Buy
- BELFA
- Analyst Count
- ETNB 8
- BELFA 0
- Target Price
- ETNB $26.29
- BELFA N/A
- AVG Volume (30 Days)
- ETNB 1.6M
- BELFA 7.6K
- Earning Date
- ETNB 08-07-2025
- BELFA 07-24-2025
- Dividend Yield
- ETNB N/A
- BELFA 0.21%
- EPS Growth
- ETNB N/A
- BELFA N/A
- EPS
- ETNB N/A
- BELFA 4.05
- Revenue
- ETNB N/A
- BELFA $594,034,000.00
- Revenue This Year
- ETNB N/A
- BELFA $21.74
- Revenue Next Year
- ETNB N/A
- BELFA $6.99
- P/E Ratio
- ETNB N/A
- BELFA $27.71
- Revenue Growth
- ETNB N/A
- BELFA 6.08
- 52 Week Low
- ETNB $4.16
- BELFA $53.95
- 52 Week High
- ETNB $11.84
- BELFA $119.30
- Technical
- Relative Strength Index (RSI)
- ETNB 45.00
- BELFA 58.37
- Support Level
- ETNB $8.95
- BELFA $111.35
- Resistance Level
- ETNB $9.50
- BELFA $118.79
- Average True Range (ATR)
- ETNB 0.54
- BELFA 2.94
- MACD
- ETNB -0.03
- BELFA -0.97
- Stochastic Oscillator
- ETNB 42.60
- BELFA 26.45
About ETNB 89bio Inc.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
About BELFA Bel Fuse Inc.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.